Javascript must be enabled to continue!
RP HPLC Method for Estimation of Dapagliflozin and Vildagliptin Incorporating Green Solvent Extraction
View through CrossRef
A simple, accurate, and precise RP-HPLC method was developed for the simultaneous estimation of Dapagliflozin and Vildagliptin in tablet dosage form, incorporating a green sample preparation approach using a Deep Eutectic Solvent (DES) composed of choline chloride and urea (1:2 molar ratio). The use of DES in place of conventional organic solvents significantly reduces environmental impact and supports sustainable analytical practices. The retention times for Dapagliflozin and Vildagliptin were found to be 2.163 min and 2.684 min, respectively. The method demonstrated excellent precision, with %RSD values of 0.3 for Dapagliflozin and 1.0 for Vildagliptin. Recovery studies showed 100.45% and 99.33% for Dapagliflozin and Vildagliptin, respectively. The method exhibited high sensitivity, with LOD and LOQ values of 0.006 μg/mL and 0.019 μg/mL for Dapagliflozin, and 0.22 μg/mL and 0.66 μg/mL for Vildagliptin. The regression equations were y = 50048x + 1180.1 for Dapagliflozin and y = 25331x + 3601.2 for Vildagliptin. The run time was significantly reduced, making the method both economical and environmentally friendly. This novel green analytical method is suitable for routine quality control analysis in pharmaceutical industries.
GP Innovations Pvt. Ltd.
Title: RP HPLC Method for Estimation of Dapagliflozin and Vildagliptin Incorporating Green Solvent Extraction
Description:
A simple, accurate, and precise RP-HPLC method was developed for the simultaneous estimation of Dapagliflozin and Vildagliptin in tablet dosage form, incorporating a green sample preparation approach using a Deep Eutectic Solvent (DES) composed of choline chloride and urea (1:2 molar ratio).
The use of DES in place of conventional organic solvents significantly reduces environmental impact and supports sustainable analytical practices.
The retention times for Dapagliflozin and Vildagliptin were found to be 2.
163 min and 2.
684 min, respectively.
The method demonstrated excellent precision, with %RSD values of 0.
3 for Dapagliflozin and 1.
0 for Vildagliptin.
Recovery studies showed 100.
45% and 99.
33% for Dapagliflozin and Vildagliptin, respectively.
The method exhibited high sensitivity, with LOD and LOQ values of 0.
006 μg/mL and 0.
019 μg/mL for Dapagliflozin, and 0.
22 μg/mL and 0.
66 μg/mL for Vildagliptin.
The regression equations were y = 50048x + 1180.
1 for Dapagliflozin and y = 25331x + 3601.
2 for Vildagliptin.
The run time was significantly reduced, making the method both economical and environmentally friendly.
This novel green analytical method is suitable for routine quality control analysis in pharmaceutical industries.
Related Results
Effectiveness, Safety and Tolerability of Vildagliptin and Vildagliptin+Metformin in Real-world Setting in the Philippines—Results from the GUARD Study
Effectiveness, Safety and Tolerability of Vildagliptin and Vildagliptin+Metformin in Real-world Setting in the Philippines—Results from the GUARD Study
Introduction: GUARD (vildaGliptin clinical Use in reAl woRlD) was a multinational, prospective, observational study that assessed the effectiveness, safety and tolerability of vild...
Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA)
Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA)
During forced degradation, the intrinsic stability of active pharmaceutical ingredients (APIs) could be determined and possible impurities that would occur during the shelf life of...
Effect of dapagliflozin on paracetamol-induced hepatotoxicity and nephrotoxicity in type 2 diabetic albino rats
Effect of dapagliflozin on paracetamol-induced hepatotoxicity and nephrotoxicity in type 2 diabetic albino rats
Introduction: paracetamol (PARA) is a worldwide antipyretic and analgesic medication. It has been extensively utilized during the last few years. PARA abuse would lead to liver and...
Development and Validation of UV Spectroscopic Method for Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin in bulk and Pharmaceutical Dosage Form
Development and Validation of UV Spectroscopic Method for Simultaneous Estimation of Remogliflozin Etabonate and Vildagliptin in bulk and Pharmaceutical Dosage Form
A new, simple, precise, accurate, reproducible, and efficient UV spectroscopic method was developed and validated for simultaneous estimation of Remogliflozin Etabonate and Vildagl...
Expert viewpoint on the position of Vildagliptin in a cardiology clinic in Indian clinical settings
Expert viewpoint on the position of Vildagliptin in a cardiology clinic in Indian clinical settings
Objective: To analyze the opinion of Indian clinical experts on the current usage patterns of vildagliptin in the treatment of patients with type 2 diabetes mellitus (T2DM) and car...
Budget impact of vildagliptin
Budget impact of vildagliptin
Introduction: to evaluate the impact on the Italian National Health Service (NHS) budget of the recent introduction of the DPP-4 inhibitor vildagliptin in combination treatment for...
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice
AbstractBrowning of white adipose tissue (WAT) is become an appealing target for therapeutics in the treatment of obesity and related metabolic diseases. Dapagliflozin is widely us...
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice
Abstract
Browning of white adipose tissue (WAT) is become an appealing target for therapeutics in the treatment of obesity and related metabolic diseases. Dapagliflozin is ...

